Online citations, reference lists, and bibliographies.
← Back to Search

Effect Of Modification Protocols On The Effectiveness Of Gold Nanoparticles As Drug Delivery Vehicles For Killing Of Breast Cancer Cells

Zahrah Alhalili, Daniela Figueroa, M. Johnston, J. Shapter, B. Sanderson
Published 2016 · Chemistry

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The current study evaluated the potential of gold nanoparticles (AuNPs) for the delivery of Taxol to breast cancer cells (T47D) using an in vitro cell culture model. For this study, new loading approaches and novel chemical attachments were investigated. Five different gold nanoparticle-based complexes were used to determine their cytotoxicity towards T47D cells using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) viability assay. There was no significant decrease (P > 0.05) in cell viability when T47D cells were treated with AuNPs that did not contain Taxol. However, cells were significantly killed by gold nanoparticles chemically conjugated to Taxol using three different approaches and one novel hybrid AuNP-Taxol nanoparticle, wherein no chemical bonds were involved. These Taxol-loaded AuNPs were more effective at inducing cell death in vitro than a solution of free Taxol used to treat cells. This result demonstrated that Taxol could be released from the particles in the cell culture media for subsequent therapeutic action. Additionally, the experiments proved that the Taxol-loaded AuNPs were more toxic in a dose dependent manner than Taxol as a formulation for the treatment of breast cancer cells. The results of this study suggest that gold nanoparticles have potential for the efficient delivery of Taxol to breast cancer cells. This could provide a future solution as an alternative application method to overcome adverse side effects resulting from current high-dose treatment regimes.
This paper references
10.1016/J.COLSURFB.2006.08.005
Extinction coefficient of gold nanoparticles with different sizes and different capping ligands.
X. Liu (2007)
10.1016/j.ijpharm.2011.05.014
Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel.
C. Wang (2011)
Gezairy, in EMRO Technical Publications Series
H A. (2006)
10.1021/BM049427E
Ligand density effect on biorecognition by PEGylated gold nanoparticles: regulated interaction of RCA120 lectin with lactose installed to the distal end of tethered PEG strands on gold surface.
Seiji Takae (2005)
10.1016/j.biomaterials.2011.09.064
Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy.
D. N. Heo (2012)
10.3390/nano1010031
Functionalized Gold Nanoparticles and Their Biomedical Applications
P. Tiwari (2011)
10.1021/JA010437M
Quantitative and Reversible Lectin-Induced Association of Gold Nanoparticles Modified with α-Lactosyl-ω-mercapto-poly(ethylene glycol)
H. Otsuka (2001)
10.1016/j.dld.2013.03.019
Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders.
H. Laroui (2013)
10.1016/J.CARBON.2007.08.010
The reliability and limits of the MTT reduction assay for carbon nanotubes-cell interaction
L. Belyanskaya (2007)
10.1200/JCO.2005.04.937
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer.
W. Gradishar (2005)
10.1016/j.jsps.2013.06.007
Engineering erythrocytes as a novel carrier for the targeted delivery of the anticancer drug paclitaxel.
G. I. Harisa (2014)
10.1016/J.BMC.2007.03.041
Improved biochemical strategies for targeted delivery of taxoids.
T. Ganesh (2007)
10.1021/NN3030223
Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing.
João Conde (2012)
10.1021/LA036365P
Polymer size and concentration effects on the size of gold nanoparticles capped by polymeric thiols.
Robert G. Shimmin (2004)
10.1002/JBM.A.31524
Biomechanical properties of carbodiimide crosslinked collagen: influence of the formation of ester crosslinks.
F. Everaerts (2008)
10.1021/JA075181K
Paclitaxel-functionalized gold nanoparticles.
J. Gibson (2007)
Mater
D. Granchi (1996)
10.1136/oem.57.11.727
In vitro toxicology of respirable Montserrat volcanic ash
M. Wilson (2000)
10.4236/JBNB.2011.225062
Recent Advances in Drug Delivery Systems
N. Martinho (2011)
10.1016/J.IJPHARM.2005.08.010
NMR characterization of paclitaxel/poly (styrene-isobutylene-styrene) formulations.
Jian-zhong Chen (2005)
10.1016/J.TIV.2005.06.034
In vitro toxicity of nanoparticles in BRL 3A rat liver cells.
S. Hussain (2005)
10.1016/j.biomaterials.2013.09.008
The performance of thiol-terminated PEG-paclitaxel-conjugated gold nanoparticles.
Y. Ding (2013)
10.1021/ja804947u
Targeted Paclitaxel by conjugation to iron oxide and gold nanoparticles.
J. R. Hwu (2009)
10.1007/s11095-013-1156-7
Nanotechnology-Based Drug Delivery Systems for Targeting, Imaging and Diagnosis of Neurodegenerative Diseases
S. Pehlivan (2013)
Application of nanotechnology in biomedicine.
Rajshri M Navalakhe (2007)
10.1016/j.ijbiomac.2011.12.034
Design and characterization of antitumor drug paclitaxel-loaded chitosan nanoparticles by W/O emulsions.
J. Xu (2012)
10.1517/17425247.5.3.263
Emerging application of quantum dots for drug delivery and therapy
Lifeng Qi (2008)
10.1021/JP036310W
Two-Step Functionalization of Neutral and Positively Charged Thiols onto Citrate-Stabilized Au Nanoparticles
Shu-Yi Lin (2004)
10.3322/CA.2007.0003
Application of Nanotechnology in Cancer Therapy and Imaging
X. Wang (2008)
10.1021/la901270x
Gold nanoparticles with a polymerizable surfactant bilayer: synthesis, polymerization, and stability evaluation.
A. AlKilany (2009)
10.1016/0378-5173(96)04443-2
Solubility and stability of taxol: effects of buffers and cyclodextrins
S. Dordunoo (1996)
10.1093/MUTAGE/17.3.261
Low molecular weight polyethylene glycol induces chromosome aberrations in Chinese hamster cells cultured in vitro.
O. Biondi (2002)
10.1016/j.ijpharm.2013.06.046
Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment.
N. Larson (2013)
10.1177/146642407409400210
(b)
Miss A.O. Penney (1974)
10.1002/JBM.B.30823
In vitro biological effects of sodium titanate materials.
R. R. Davis (2007)
10.2147/IJN.S15839
Novel free paclitaxel-loaded poly(L-γ-glutamylglutamine)–paclitaxel nanoparticles
Danbo Yang (2011)
10.1002/(SICI)1097-4636(199606)31:2<183::AID-JBM4>3.0.CO;2-J
Assessment of metal extract toxicity on human lymphocytes cultured in vitro.
D. Granchi (1996)
10.1016/S0378-5173(96)04782-5
Solid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate
H. Heiati (1997)
10.1002/smll.200900466
Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage.
Y. Pan (2009)
10.1002/RCM.2567
Measurement of paclitaxel and its metabolites in human plasma using liquid chromatography/ion trap mass spectrometry with a sonic spray ionization interface.
H. Gréen (2006)
10.3322/caac.21203
Breast cancer statistics, 2013
C. Desantis (2014)
10.1016/J.PROENG.2013.10.004
The Potential of Gold Nanoparticle Conjugates to Kill Cancer Cells in Culture
B. Sanderson (2014)
10.1016/j.ejpb.2008.08.009
Current in vitro methods in nanoparticle risk assessment: limitations and challenges.
A. Kroll (2009)
10.1016/J.LUNGCAN.2007.10.002
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment.
Z. Lin (2008)
10.1259/bjr/59448833
Gold nanoparticles as novel agents for cancer therapy.
S. Jain (2012)
10.1093/TOXSCI/KFM018
Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.
C. Sayes (2007)
10.1016/J.BBRC.2007.01.183
Immobilization of glucose oxidase onto gold nanoparticles with enhanced thermostability.
D. Li (2007)
10.2147/IJN.S30320
Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers
Wahajuddin (2012)
10.1002/anie.200902672
Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives.
Katrin Knop (2010)
10.1016/S1470-2045(00)00254-0
Epidemiology of breast cancer.
T. Key (2001)
10.1002/SMLL.200400093
Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity.
E. E. Connor (2005)
10.1016/j.clbc.2011.03.019
A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer.
A. Brufsky (2011)
10.1016/S1387-2656(05)11004-7
Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction.
M. Berridge (2005)
10.1002/anie.200906584
A simple spectroscopic method for differentiating cellular uptakes of gold nanospheres and nanorods from their mixtures.
E. Cho (2010)
10.1021/AC00100A008
Preparation and Characterization of Au Colloid Monolayers
K. C. Grabar (1995)
Angew
E. C. Cho (1976)
10.1021/BC049951I
Toxicity of gold nanoparticles functionalized with cationic and anionic side chains.
Catherine M Goodman (2004)
10.1039/DF9511100055
A study of the nucleation and growth processes in the synthesis of colloidal gold
J. Turkevich (1951)
10.1002/jbm.a.35222
An investigation of common crosslinking agents on the stability of electrospun collagen scaffolds.
G. P. Huang (2015)
10.1016/0022-1759(83)90303-4
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.
T. Mosmann (1983)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar